Teva Pharmaceuticals is buying Allergan’s generic drug business for $40.5 billion.

The Israeli pharmaceutical signed an agreement on 27 July for Allergan Generics and withdrew its plans to acquire Mylan’s business.

Under the new agreement, Teva will pay Allergan $33.75 billion in cash for the generics unit.

…Full Story